Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px
Organisation › Details

Scipher Medicine (US)

Scipher Medicine, a precision immunology company, holds the fundamental belief that patients deserve simple answers to treatment options based on scientifically backed data. Leveraging our proprietary Network Medicine platform and artificial intelligence, we commercialize blood tests identifying a patient’s unique molecular disease signature and match such signature to most effective therapy ensuring patients receive optimal treatment from day one. The unprecedented amount of patient molecular data generated from our tests further drives development of novel and more effective therapeutics. We partner with payers, providers and pharma along the health care value chain to bring precision medicine to autoimmune diseases. Scipher Medicine is backed by Khosla Ventures, Northpond Ventures and UnitedHealth Group. *


Period Start 2015-01-01 established
Products Industry Network Medicine Platform
  Industry 2 personalised medicine / precision medicine
Person Person Saleh, Alif (Scipher Medicine 202008 CEO)
Region Region Waltham, MA
  Country United States (USA)
  Street 260 Charles Street
  City 02453 Waltham, MA
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Galapagos N.V.. (8/12/20). "Press Release: Scipher Medicine and Galapagos Sign Collaboration in Inflammatory Bowel Disease". Mechelen & Boston, MA.
Record changed: 2021-03-26


Picture [iito] Plain Stupid Simple 650x80px

More documents for Scipher Medicine (US)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC B Preview Download 650x300px

» top